Back pain breakthrough? study seeks clues to who benefits from nerve scar treatment

NCT ID NCT07487935

Ongoing Knowledge-focused Sponsor: Mersin University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study reviews medical records of 40 adults with chronic leg pain from back problems who had a procedure called caudal epidural adhesiolysis. The procedure uses a thin tube to break up scar tissue around spinal nerves. Researchers want to find out which patient traits or procedure details lead to better pain relief. The goal is to help doctors choose the right patients for this treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: caudal epidural adhesiolysis (a minimally invasive procedure to break up scar tissue around spinal nerves)
What this could lead to: If successful, this study could help doctors identify which patients with chronic back and leg pain are most likely to benefit from this procedure, leading to better treatment decisions.
What could go wrong: This is a small, single-center retrospective study (only 40 patients) that looks back at medical records, so it cannot prove cause and effect. Results may not apply to other clinics or patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADHESIOLYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lumbar disk degenerative disorder lumbar disk disease radiculopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADHESIOLYSIS DISC DISEASE LUMBAR RADICULAR PAIN

Contacts and locations

Locations

Mersin University Faculty of Medicine, Department of Pain Medicine

Mersin, Ciftlikkoy, 33110, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.